Parallel Advisors’s Castle Biosciences CSTL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $570K | Buy |
27,893
+300
| +1% | +$6.13K | 0.01% | 584 |
|
|
2025
Q1 | $551K | Sell |
27,593
-402
| -1% | -$8.02K | 0.01% | 552 |
|
|
2024
Q4 | $746K | Buy |
27,995
+3
| +0% | +$80 | 0.02% | 466 |
|
|
2024
Q3 | $798K | Buy |
27,992
+1,524
| +6% | +$43.5K | 0.02% | 433 |
|
|
2024
Q2 | $576K | Sell |
26,468
-200
| -0.7% | -$4.35K | 0.01% | 493 |
|
|
2024
Q1 | $591K | Sell |
26,668
-300
| -1% | -$6.65K | 0.02% | 483 |
|
|
2023
Q4 | $582K | Hold |
26,968
| – | – | 0.02% | 449 |
|
|
2023
Q3 | $455K | Sell |
26,968
-87
| -0.3% | -$1.47K | 0.02% | 482 |
|
|
2023
Q2 | $371K | Buy |
27,055
+4,986
| +23% | +$68.4K | 0.01% | 558 |
|
|
2023
Q1 | $501K | Hold |
22,069
| – | – | 0.02% | 464 |
|
|
2022
Q4 | $520K | Sell |
22,069
-22
| -0.1% | -$518 | 0.02% | 395 |
|
|
2022
Q3 | $576K | Hold |
22,091
| – | – | 0.03% | 357 |
|
|
2022
Q2 | $485K | Buy |
22,091
+182
| +0.8% | +$4K | 0.02% | 403 |
|
|
2022
Q1 | $964K | Buy |
21,909
+140
| +0.6% | +$6.16K | 0.04% | 274 |
|
|
2021
Q4 | $933K | Hold |
21,769
| – | – | 0.03% | 284 |
|
|
2021
Q3 | $1.45M | Sell |
21,769
-22
| -0.1% | -$1.46K | 0.06% | 202 |
|
|
2021
Q2 | $1.6M | Buy |
21,791
+1,791
| +9% | +$131K | 0.07% | 190 |
|
|
2021
Q1 | $1.37M | Sell |
20,000
-5,000
| -20% | -$342K | 0.06% | 191 |
|
|
2020
Q4 | $1.68M | Sell |
25,000
-14,420
| -37% | -$968K | 0.09% | 156 |
|
|
2020
Q3 | $2.03M | Buy |
39,420
+19,420
| +97% | +$999K | 0.13% | 133 |
|
|
2020
Q2 | $753K | Buy |
+20,000
| New | +$753K | 0.05% | 219 |
|